BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials, today announced that new test results indicate its VitroStealth® coating can be used in the design of biosensors, such as those for continuous glucose monitoring. VitroStealth® coating is a durable and non-fouling coating designed to prevent unwanted protein absorption and cellular adhesion on synthetic surfaces. Study data indicates that VitroStealth® coating does not inhibit the transport of glucose or oxygen through coated filters. This opens the door to its application in the design of biosensors, where permeability and non-fouling are important requirements.
With these characteristics, VitroStealth® coating is expected to improve the performance of long-term, in-vivo diagnostic devices like biosensors. For example, VitroStealth® coating is designed to prevent protein adhesion, thereby increasing the longevity of biosensors and extending the time of accurate signal transmission. The device can remain in the patient for a longer period of time, which improves cost efficiency. VitroStealth® coatings characteristics also indicate its application in the design of in-vitro diagnostics, such as point-of-care capillaries, blood capillaries and microfluidic devices, and ex-vivo tools, such as blood filters and pre-filled syringes.
"As DSM continues to break new ground in biomedical materials and technology we are excited to expand VitroStealth® coating further in the medical diagnostic arena though collaborative relationships with innovative companies," said John Marugg, Business Manager, Coatings, DSM Biomedical. "The advanced VitroStealth® coating technology has the potential to be used in an expanding array of applications that can ultimately help manage or improve the health of patients."
DSM – Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSMs 22,000 employees deliver annual net sales of about â‚¬ 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.